Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Last Updated: June 25, 2022

Litigation Details for AbbVie Inc. v. Hetero USA Inc. (D. Del. 2013)

✉ Email this page to a colleague

« Back to Dashboard

AbbVie Inc. v. Hetero USA Inc. (D. Del. 2013)

Docket	See Plans and Pricing	Date Filed	2013-05-15
Court	District Court, D. Delaware	Date Terminated	2014-11-17
Cause	35:271 Patent Infringement	Assigned To	Richard Gibson Andrews
Jury Demand	None	Referred To
Parties	ABBVIE INC.; HETERO LABS LIMITED
Patents	6,037,157; 6,703,403; 7,148,359; 7,364,752; 8,268,349; 8,691,878
Attorneys	Chad A. Landmon; Diane C. Ragosa
Firms	Morris, Nichols, Arsht & Tunnell
Link to Docket	External link to docket

Small Molecule Drugs cited in AbbVie Inc. v. Hetero USA Inc.

The small molecule drugs covered by the patents cited in this case are See Plans and Pricing , See Plans and Pricing , See Plans and Pricing , See Plans and Pricing , See Plans and Pricing , and See Plans and Pricing .

Details for AbbVie Inc. v. Hetero USA Inc. (D. Del. 2013)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try it Free
Date Filed	Document No.	Description	Snippet	Link To Document
2013-05-15	1		’349 patent”), United States Patent No. 6,037,157 (“the ’157 patent”), and United States Patent No. 6,703,403…FOURTH COUNT FOR PATENT INFRINGEMENT UNITED STATES PATENT NO. 6,037,157 83.…-417 nor patent owner of the ’359 patent, the ’752 patent, the ’349 patent, the ’157 patent or the ’403…action for patent infringement of United States Patent Number 7,148,359 B2 (“the ’359 patent”), United…United States Patent Number 7,364,752 B1 (“the ’752 patent”), United States Patent No. 8,268,349 B2 (“the	External link to document
2013-05-15	4		; 7,364,752 B1; 8,268,349 B2; 6,037,157; 6,703,403 B2;. (mdb) (Entered: 05/16/2013) 15 May 2013 … Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,148,359 B2; … 18 November 2014 1:13-cv-00852 830 Patent None District Court, D. Delaware	External link to document
2014-10-22	93		AbbVie's Disclosure of Asserted Claims for U.S. Patent No. 8,691,878 B2 filed by AbbVie Inc., Abbvie Deutschland… 18 November 2014 1:13-cv-00852 830 Patent None District Court, D. Delaware	External link to document
2014-11-19	99		; 7,364,752 B1; 8,268,349 B2; 6,037,157; 6,703,403 B2. (Attachments: # 1 Order)(nms) (Entered: 11/20/2014… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,148,359 B2; … 18 November 2014 1:13-cv-00852 830 Patent None District Court, D. Delaware	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt

Dow

Moodys

Harvard Business School

Johnson and Johnson

Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.